• Wednesday
  • September 24, 2014
  • Last updated: 2:37am
Hong Kong

Humidity 

UV 

Pollution 

Search Results

Results 1 - 10 of 1048 for baoshantang pharmaceutical company

Related topics matching your search

Search results

  1. Take your guess for Fosun Pharma pricing

    Posted Apr 30th 2012, 12:00am

    ... trades on the Shanghai Stock Exchange. The deal has a lot going for it, but local investors may ultimately puzzle over how to value the company. The pharmaceuticals sector is vastly ... pharmaceutical companies. It's a bit unclear what exactly constitutes Fosun Pharmaceutical's core business. Investors in the new listing will have to understand, or at least get comfortable, ...

    http://www.scmp.com/article/999631/take-your-guess-fosun-pharma-pricing
  2. It's buyer beware when acquiring mainland companies

    Posted Apr 27th 2006, 12:00am by Tom Holland

    ... the country's state banks. However, M&A advisers report there is also keen demand to buy into companies in the consumer, electronics, steel and pharmaceutical sectors. Some of that interest has been ... Tom Holland Buying into Chinese companies is getting easier and the number and scale of attempted purchases by foreign buyers is only likely to increase. Even so, investors hoping ...

    http://www.scmp.com/article/546446/its-buyer-beware-when-acquiring-mainland-companies
  3. Health-care funds fit to buy

    Posted Mar 14th 2007, 12:00am by Allan Nam

    ... potential', despite the malaise now afflicting pharmaceutical companies. The company won the three-year health-care sector trophy in the Fund Awards 2007. Share prices in the pharmaceutical industry, ... cord treatments. The fund's flexible investment approach has also allowed Ms Ezendam to position the portfolio to benefit from pharmaceutical companies which could add value ...

    http://www.scmp.com/article/584893/health-care-funds-fit-buy
  4. Guilin Sanjin targets 920m yuan in IPO

    Posted Jun 24th 2009, 12:00am by Staff Reporter

    ... Daniel Ren in Shanghai Guilin Sanjin Pharmaceutical, the first company to launch an initial public share offering on the mainland after an unofficial nine-month ban, may raise as much ... bid to damp buying frenzy The pharmaceutical company may price its shares as high as, in yuan: 20 yuan ...

    http://www.scmp.com/article/684695/guilin-sanjin-targets-920m-yuan-ipo
  5. Shineway IPO offer swamped 230 times

    Posted Nov 30th 2004, 12:00am by Staff Reporter

    ... Hui Yuk-min and Nichole Chan China Shineway Pharmaceutical Group is leading an end-of-year initial public offering frenzy, with demand for shares being oversubscribed 230 times by retail investors. Analysts said demand for the Chinese medicine maker was a good indicator for a string of about a dozen companies queueing up to raise fresh capital before fund managers took ...

    http://www.scmp.com/article/480131/shineway-ipo-offer-swamped-230-times
  6. United Labs prices IPO shares at top end

    Posted Jun 09th 2007, 12:00am by Staff Reporter

    ... The international offering was more than 40 times covered, the source said. The sale was arranged by HSBC. 'Traditional investment funds are keen to buy pharmaceutical stocks worldwide because of the tremendous growth in global pharmaceutical sales. On the other hand, local investors are not interested,' said the source. The proceeds of the share offering will be used to expand ...

    http://www.scmp.com/article/596016/united-labs-prices-ipo-shares-top-end
  7. UPGRADES AND DOWNGRADES

    Posted Jun 16th 2004, 12:00am by Staff Reporter

    ... 'buy' on rising risk concerns after the mainland pharmaceutical firm said it would spend $453 million on a 51 per cent stake in a start-up company. 'We see tremendous growth potential from ... with a 'buy' recommendation, saying the stock is 'totally undervalued' at 12 times 2005 earnings. The computer graphics animation (CGI) company, formerly Christmas tree maker Boto ...

    http://www.scmp.com/article/459635/upgrades-and-downgrades
  8. Beijing puts squeeze on IPOs amid slow market

    Posted Mar 03rd 2011, 12:00am by Staff Reporter

    ... committee rejected a record 65 companies. This year, a chorus of protests from mainland media and Web users greeted the IPO application of Gui Zhen Tang Pharmaceutical, which operates bear bile ... 'But it seems the slowdown would be temporary rather than permanent since hundreds of companies are still desperate for IPO proceeds.' The mainland was the world's largest IPO market ...

    http://www.scmp.com/article/739734/beijing-puts-squeeze-ipos-amid-slow-market
  9. Noble gets high premium for bond

    Posted May 17th 2007, 12:00am by Staff Reporter

    ... Tim LeeMaster Noble Group, a Hong Kong-based logistics company, raised US$250 million from selling convertible bonds with a sky-high conversion premium of 65 per cent, taking advantage ... said. The company initially raised US$200 million on Tuesday before exercising a US$50 million greenshoe option yesterday morning, after the bond traded up after the market close. Citigroup ...

    http://www.scmp.com/article/593130/noble-gets-high-premium-bond
  10. Fortune favours the brave

    Posted Nov 28th 2011, 12:00am

    ... 'First, go defensive and never mind the nationality of the stock. Food, pharmaceuticals, utilities and retail. In particular, retail, which is trying to get into the frontier markets of Africa. ... class out there, provided investors do their homework. 'Balance sheets for companies are the best I have ever seen,' Raif says. 'Companies are lean and efficient, ...

    http://www.scmp.com/article/986165/fortune-favours-brave

Pages

Login

SCMP.com Account

or